Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia® (denosumab) for the treatment of postmenopausal osteoporosis‡

Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia® (denosumab) for the treatment of postmenopausal osteoporosis‡

Bibliographic Details
Main Authors: Xue, Fei, Ma, Haijun, Stehman-Breen, Catherine, Haller, Christine, Katz, Leonid, Wagman, Rachel B, Critchlow, Cathy W, Denosumab Global Safety Assessment Team
Format: Online
Language:English
Published: BlackWell Publishing Ltd 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230463/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230463/

Similar Items